EMA Authorised: Temozolomide Accord (temozolomide) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Temozolomide Accord (temozolomide) from Accord Healthcare S.L.U. for glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temozolomide Accord (temozolomide)

Snippet

Status: Authorised. Therapeutic area: Glioma. MAH: Accord Healthcare S.L.U.. Decision date: 28/05/2025